Page numbers printed in boldface type refer to tables.
Accreditation Council for Graduate Medical Education (ACGME),222
Addictive disorders.
See Substance-related and addictive disorders
Adolescents.
See also Children
gender dysphoria in DSM-5-TR,128–129
Adultsgender dysphoria in DSM-5-TR,128–129
maltreatment and neglect problems,186–
188Affect.
See Emotions
Age.
See Adolescents; Adults; Children
Alcoholics Anonymous,16
Alcohol intoxication, in DSM-5-TR,136–137
Alcohol use disorder,50
in DSM-5-TR,134–136
Alcohol withdrawal, in DSM-5-TR,137
Allergies,32
Alliance building.
See Therapeutic alliance
Alzheimer’s disease,165
American Board of Psychiatry and Neurology (ABPN), clinical skills evaluation,221–223
Amnesia.
See Dissociative amnesia
Anorexia nervosa, in DSM-5-TR,110–111
Antisocial personality disorder dimensional diagnosis of,252–254
in DSM-5-TR,173
Anxiety,30, 93.
See also Anxiety disorders; Illness anxiety disorder
dimensions and,42
Anxiety disorders, in DSM-5-TR,92–96,
199Anxiolytic use disorder.
See Sedative, hypnotic, or anxiolytic intoxication; Sedative, hypnotic, or anxiolytic use disorder
Appetite.
See Eating and feeding
Ataque de nervios (intense emotional response among Latinx),46, 47
Attention-deficit/hyperactivity disorder, in DSM-5-TR,77–79,
196Attention-seeking,62.
See also Personality disorders
Attenuated psychotic syndrome,54
Autism spectrum disorder, in DSM-5-TR,74–77,
196Avoidant personality disorder dimensional diagnosis of,247–249
in DSM-5-TR,176–177
Avoidant/restrictive food intake disorder, in DSM-5-TR,111–113
Behaviorassociations with suicidal thoughts,49
catatonic,80
compulsive,97
eccentric,81
nonverbal communicative behaviors,74
socially deviant,11
suicidal,183Bentall, Richard,7
Bereavement,55.
See also Death; Grief
Binge eating,111.
See also Feeding and eating disorders
Bipolar and related disorders, in DSM-5-TR,83–87,
198Bipolar I disorder, in DSM-5-TR,83–85,
198Bipolar II disorder, in DSM-5-TR,85–87,
198Blame,101
BMI,110.
See also Feeding and eating disorders
Board certification.
See American Board of Psychiatry and Neurology (ABPN), clinical skills evaluation
Borderline personality disorder dimensional diagnosis of,243–245
in DSM-5-TR,174
Bordin, Edward,15
Caffeine intoxication, in DSM-5-TR,138
Caffeine withdrawal, in DSM-5-TR,139
Cannabis intoxication, in DSM-5-TR,141
Cannabis use disorder, in DSM-5-TR,139–141
Cannabis withdrawal, in DSM-5-TR,141–142
Cannon, Joanna,25
Caregiver, goals of,217–219,
219–
220Case examplesof death,54–55
of major depressive disorder,54–55
of neurocognitive disorder,56–59
of personality disorder,59–60
of schizophrenia,51–52
Catatonic behavior,80
Categorical models,6–7, 50, 60
Child abuse.
See Psychosocial functioning
Children.
See also Adolescents
child maltreatment and neglect problems,183–
186gender dysphoria in DSM-5-TR,127–128
Clinical skills evaluations (CSEs),221–223
Clinician-Rated Dimensions of Psychosis Symptom Severity,227,
228–
230Clumsiness,76
Cognition.
See also Memories; Neurocognitive disorders
mental status examination during,213
Cognitive-behavioral therapy, therapeutic alliance and,15–16
Cohen, Henry,5
Communication.
See also Therapeutic alliance with patient,22
Communication disorder,73
Compulsions,31.
See also Obsessions
Conduct disorder, in DSM-5-TR,130–134
Confidentiality,22
Counseling,191Cultural explanation of perceived cause,47
Cultural Formulation Interview (CFI),20
as assessment measure,225–227
description of,47–48
Cultural idiom of distress,47
Cultural syndrome,47
Culture.
See also Religion; Therapeutic alliance
diagnostic issues and assessments,45–48
Culture-specific diagnostic systems,257
Death,102–103.
See also Bereavement; Major depressive disorder; Suicide
case example of,54–55
Deficits.
See Neurodevelopmental disorders
Delirium,58.
See also Neurocognitive disorder
in DSM-5-TR,163–164,
201Delusions,52, 80, 81.
See also Schizophrenia
Dependent personality disorder, in DSM-5-TR,177
Depersonalization/derealization disorder, in DSM-5-TR,105–106
Depressive disorders.
See also Major depressive disorder
in DSM-5-TR,87–91,
199Derealization disorder.
See Depersonalization/derealization disorder
Detachment,101, 105–106
Developmental problems, questions about,205–206.
See also Children; Neurodevelopmental disorders
Dhat syndrome,46
Diagnosis.
See specific disordersDiagnostic interview.
See also Dimensions, personalizing diagnoses through; 15-minute diagnostic interview; Therapeutic alliance; 30-minute diagnostic interview
alcohol intoxication and,136–137
alcohol use disorder and,134–136
alcohol withdrawal and,137
alternative personality disorders and,178–179
anorexia nervosa and,110–111
antisocial personality disorder and,173
anxiety disorders and,92–96
attention-deficit/hyperactivity disorder and,77–79
autism spectrum disorder and,74–77
avoidant personality disorder and,176–177
avoidant/restrictive food intake disorder and,111–113
bipolar and related disorders and,83–87
bipolar I disorder and,83–87
bipolar II disorder and,85–87
borderline personality and,174
caffeine intoxication and,138
caffeine withdrawal and,139
cannabis intoxication and,141
cannabis use disorder and,139–141
cannabis withdrawal and,141–142
communication with patient,22
conduct disorder and,130–134
delirium and,163–164
dependent personality disorder and,177
depersonalization/derealization disorder and,105–106
depressive disorders and,87–91
disorders vs. illnesses or disease,8
disruptive, impulse-control, and conduct disorders and,129–134
disruptive mood dysregulation disorder and,91
dissociative amnesia and,104–105
dissociative disorders and,104–106
elimination disorders and,113–114
empathy during,25
encopresis and,114
enuresis and,113
erectile disorder and,122–123
feeding and eating disorders and,109–113
female orgasmic disorder and,123–124
female sexual interest/arousal disorder and,124–126
follow-up questions,34
gambling disorder and,161–162
gender dysphoria and,127–129
gender dysphoria in children and,127–128
generalized anxiety disorder and,95–96
histrionic personality disorder and,174–175
hypersomnolence disorder and,116–118
illness anxiety disorder and,108–109
inhalant intoxication and,146–147
inhalant use disorder and,145–146
insomnia disorder and,115–116
intellectual developmental disorder (intellectual disability) and,71–74
intermittent explosive disorder and,129–130
introduction,3–7
major depressive disorder and,87–91
major neurocognitive disorder and,164–167
male hypoactive sexual desire disorder and,126–127
mild neurocognitive disorder and,168
narcissistic personality disorder and,175–176
narcolepsy and,118–119
neurocognitive disorders and,162–168
neurodevelopmental disorders and,71–79
nonverbal cues,22, 24
obsessive-compulsive and related disorders and,96–99
obsessive-compulsive personality disorder and,177–178
obstructive sleep apnea hypopnea and,119–120
opioid intoxication and,149
opioid use disorder and,147–148
opioid withdrawal and,149–150
other (or unknown) substance intoxication,161
other (or unknown) substance use disorder and,159–161
other (or unknown) substance withdrawal and,161
panic disorder and,93–95
paranoid personality disorder and,170–171
paraphilic disorders and,179–181
patient confidentiality,22
personality disorders in,169–179
phencyclidine or other hallucinogen intoxication and,144
phencyclidine or other hallucinogen use disorder and,142–144
posttraumatic stress disorder and,99–103
questions produced by,13–14
reactive attachment disorder and,103–104
restless legs syndrome and,120–121
schizoid personality disorder and,171–172
schizophrenia spectrum and other psychotic disorders and,79–82
schizotypal personality disorder and,172–173
science of,17
sedative, hypnotic, or anxiolytic intoxication and,152
sedative, hypnotic, or anxiolytic use disorder and,150–152
sedative, hypnotic, or anxiolytic withdrawal and,152–153
setting expectations,22–23
sexual dysfunctions and,121–127
sleep-wake disorders and,114–121
somatic symptom and related disorders and,106–109
somatic symptom disorder and,107–108
specific phobias and,92–93
stimulant intoxication and,155–156
stimulant use disorder and,153–155
stimulant withdrawal and,156–157
substance-related an addictive disorders and,134–162
tobacco use disorder and,157–158
tobacco withdrawal and,158–159
trauma- and stressor-related disorders in,99–104
Diagnostic systems and rating scales.
See also International Statistical Classification of Diseases and Related Health Problemsculture-specific diagnostic systems,257
Hierarchical Taxonomy of Psychopathology (HiTOP),258–259
Psychodynamic Diagnostic Manual (PDM-2),258
McHugh’s clusters,260–261
Power Threat Meaning Framework (PTM),259–260
rating scales,262
Research Domain Criteria (RDoC),261
Differential diagnosis, questions to,203–207
Dimensional diagnosis of personality disorders.
See also Personality disorders
level of personality functioning scale,232,
233–
237overview,231–232
personality trait rating form,238,
239–
242Dimensions, personalizing diagnoses through.
See also DSM-5-TR
associations with suicidal thoughts or behavior,49
cultural-related diagnostic issues and assessments,45–48
model,43
personality disorders and,60–61
screening tools for,44–45
severity ratings,43–44
sex- and gender-related diagnostic issues,48–49
symptoms and,41
Diseases.
See also Disorders; specific diseases
vs. disorders or illnesses,9–10
Disorders.
See also Diseases;
specific disordersdescription of,9, 215–216
vs. illnesses or diseases,8
Disorganized speech,52.
See also Schizophrenia
Disruptive, impulse-control, and conduct disorders, in DSM-5-TR,129–134
Disruptive mood dysregulation disorder, in DSM-5-TR,91
Dissocial personality disorder.
See Antisocial personality disorder
Dissociate disorders, in DSM-5-TR,104–106
Dissociation,31.
See also Dissociative amnesia
Dissociative amnesia, in DSM-5-TR,104–105
Distractibility,85
Distraction,77
Dreams,100
DSM-III,6–7
DSM-IV,50
diagnostic criteria for major depressive disorder,55
DSM-5,7, 27
DSM-5-TR.
See also Dimensions, personalizing diagnoses through
alcohol intoxication in,136–137
alcohol use disorder in,134–136
alcohol withdrawal in,137
alternative personality disorders in,178–179
anorexia nervosa in,110–111
antisocial personality disorder in,173
anxiety disorders in,92–96,
199assessment measures,225–230
attention-deficit/hyperactivity disorder in,77–79,
196attenuated psychotic syndrome in,54
autism spectrum disorder in,74–77,
196avoidant personality disorder in,176–177
avoidant/restrictive food intake disorder in,111–113
bipolar and related disorders in,83–87,
198bipolar I disorder in,83–87,
198bipolar II disorder in,85–87,
198borderline personality disorder in,174
caffeine intoxication in,138
caffeine withdrawal in,139
cannabis intoxication in,141
cannabis use disorder in,139–141
cannabis withdrawal in,141–142
changes in,51
conduct disorder in,130–134
definition of mental disorder,10–13
delirium in,163–164,
201dependent personality disorder in,177
depersonalization/derealization disorder in,105–106
depressive disorders in,87–91,
199disruptive, impulse-control, and conduct disorders in,129–134
disruptive mood dysregulation disorder in,91
dissociative amnesia in,104–105
dissociative disorders in,104–106
elimination disorders in,113–114
encopresis in,114
enuresis in,113
erectile disorder in,122–123
feeding and eating disorders in,109–113
female orgasmic disorder in,123–124
female sexual interest/arousal disorder in,124–126
gambling disorder in,161–162
gender dysphoria in,127–129
in adolescents,128–129
in adults,128–129
in children,127–128
generalized anxiety disorder in,95–96,
199histrionic personality disorder in,174–175
hypersomnolence disorder in,116–118
illness anxiety disorder in,108–109
inhalant intoxication in,146–147
inhalant use disorder in,145–146
insomnia disorder in,115–116
intellectual developmental disorder (intellectual disability) in,71–74
intermittent explosive disorder in,129–130
major depressive disorder in,55–56, 87–91,
199,
201major neurocognitive disorder in,164–167
male hypoactive sexual desire disorder in,126–127
medication-induced movement disorders and other adverse effects of medication in,182mild neurocognitive disorder in,168,
201narcissistic personality disorder in,175–176
narcolepsy in,118–119
neurocognitive disorders in,57–58, 162–168,
196,
201neurodevelopmental disorders in,71–79
obsessive-compulsive and related disorders in,96–99,
200obsessive-compulsive personality disorder in,177–178
obstructive sleep apnea hypopnea in,119–120
opioid intoxication in,149
opioid use disorder in,147–148
opioid withdrawal in,149–150
other conditions that may be a focus of clinical attention in,182–183,
183–
192 “other specified” diagnostic criteria in, 65
other (or unknown) substance intoxication in,161
other (or unknown) substance use disorder in,159–161
other (or unknown) substance withdrawal in,161
panic disorder in,93–95,
199paranoid personality disorder in,170–171
paraphilic disorders in,179–181
personality disorders in,60–64, 169–179
phencyclidine or other hallucinogen intoxication in,144
phencyclidine or other hallucinogen use disorder in,142–144
posttraumatic stress disorder in,99–103,
200reactive attachment disorder in,103–104
reordered disorders in,64–65
restless legs syndrome in,120–121
schizoaffective disorder in,197schizoid personality disorder in,171–172
schizophrenia in,51–53
schizophrenia spectrum and other psychotic disorders in,79–82,
197schizotypal personality disorder in,172–173
sedative, hypnotic, or anxiolytic intoxication in,152
sedative, hypnotic, or anxiolytic use disorder in,150–152
sedative, hypnotic, or anxiolytic withdrawal in,152–153
sexual dysfunctions in,121–127
sleep-wake disorders in,114–121
somatic symptom and related disorders in,106–109
somatic symptom disorder in,107–108
specific phobias in,92–93
stimulant intoxication in,155–156
stimulant use disorder in,153–155
stimulant withdrawal in,156–157
substance-related and addictive disorders in,134–162
tobacco use disorder in,157–158
tobacco withdrawal in,158–159
trauma- and stressor-related disorders in,99–104,
200 “unspecified” diagnostic criteria in, 65
Dysfunction, definition of,11
Dysphoric mood,149.
See also Gender dysphoria, in DSM-5-TR
Eating and feeding,31
Eccentric behavior,81
Economic problems,190Educational problems,189Elimination,32
Elimination disorders, in DSM-5-TR,113–114
Emergency services, patient referral to,40
Emotions,101
mental status examination during,211
Empathy,25
Encopresis, in DSM-5-TR,114
Enteral feeding,112.
See also Feeding and eating disorders
Enuresis, in DSM-5-TR,113
Erectile disorder.
See also Men
in DSM-5-TR,122–123
Excoriation,99
Exhibitionistic disorder,179
Exposure distress,100
Family history,32
Fantasies,175
Fear,93
Feeding and eating disorders.
See also Anorexia nervosa; Eating and feeding
in DSM-5-TR,109–113
Female orgasmic disorder.
See also Women
in DSM-5-TR,123–124
Female sexual interest/arousal disorder.
See also Women
in DSM-5-TR,124–126
Fetishistic order,180
Fidgets,77
15-minute diagnostic interview.
See also Diagnostic interview; 30-minute diagnostic interview
background information before,38
options for treatment choices,39
outline of,38–40
patient safety,38
patient’s functional status during,38
Five-Factor Model,62
Flashbacks,100
Flight of ideas,85
Forgetfulness,77
Frank, Jerome and Julia,16–17, 20–21
Frotteuristic disorder,179
Gambling disorder, in DSM-5-TR,161–162
Genderdiagnostic issues and,48–49
PTSD and,48
Gender dysphoria, in DSM-5-TR,127–129
in adolescents and adults,128–129
in children,127–128
Generalized anxiety disorder, in DSM-5-TR,95–96,
199Goal-directed activity,85
Grandiosity,62, 85.
See also Personality disorders
Grief,55, 102–103
Group therapy,16
Hallucinations,52, 80.
See also Schizophrenia
Hallucinogen use disorder.
See Phencyclidine or other hallucinogen intoxication; Phencyclidine or other hallucinogen use disorder
Health care problems,191Hierarchical Taxonomy of Psychopathology (HiTOP),258–259
Hikikomari,46
Histrionic personality disorder, in DSM-5-TR,174–175
HIV infection,57, 166
Housing problems,190Huntington’s disease,167
Hypersomnia,117
Hypersomnolence disorder, in DSM-5-TR,116–118
Hypnotic disorder.
See Sedative, hypnotic, or anxiolytic intoxication; Sedative, hypnotic, or anxiolytic use disorder
Hypocretin deficiency,118
codes,182Z codes,57, 63,
182Illness anxiety disorder, in DSM-5-TR,108–109
Illnesses, vs. disorders or disease,8
Impairment.
See also Insomnia disorder; Sleeping
definition of,11
Inhalant intoxication, in DSM-5-TR,146–147
Insight/judgment, mental status examination during,213
Insomnia disorder, in DSM-5-TR,115–116
Intellectual developmental disorder (intellectual disability), in DSM-5-TR,71–74
Intermittent explosive disorder, in DSM-5-TR,129–130
International Statistical Classification of Diseases and Related Health Problems (ICD),6, 257–258.
See also Diagnostic systems and rating scales
Interview.
See Diagnostic interview
Intimacy.
See Personality disorders; Relationships
Kernberg, Otto,23–24
questions,24
Khyál cap,46
Kleinman, Arthur, questions for patients,19
Kleptomania,133
Kufungisia,46
Language disorder,72
mental status examination during,210
Learning difficulties,74
Legal system problems,190Level 1 Cross-Cutting Symptom Measure,44–45
Level 2 Cross-Cutting Symptom Measure,45
Level of Personality Functioning Scale,43–44, 232,
233–
237Lewy body disease,165
Major depressive disorder,50.
See also Death; Depressive disorders
DSM-IV criteria for,55
case example of,54–55
in DSM-5-TR,87–91,
199DSM-5-TR criteria for,55–56
single and recurrent episodes,87–91
Major neurocognitive disorder, in DSM-5-TR,164–167,
201Maladi dyab,46
Male hypoactive sexual desire disorder.
See also Men
in DSM-5-TR,126–127
McHugh, Paul,260–261
McHugh’s clusters,260–261
Medical care problems,191.
See also specific disordersMedical conditions, questions about,204–205
Medication-induced movement disorders and other adverse effects of medicationin DSM-5-TR,182Memories,100
Men.
See Erectile disorder; Gender dysphoria; Male hypoactive sexual desire disorder
Mental disordersdiagnosis of,5–6
dimensions for screening,41–42
“dimensions of,”6
DSM-5-TR definition of,10–13
obstacles encountered,3–4
questions about,206
symptoms and signs of,4–5
understanding a person with,4
Mental health treatment planningbest practices of,220
overview,215
patient and caregiver goals,217–219,
219–
220problem lists,215–217
Mental status examination (MSE),33
appearance,209
behavior,210
cognition,213
emotion,211
insight/judgment,213
speech and language,210
thought content,212
thought process,211–212
Mild neurocognitive disorder, in DSM-5-TR,168,
201Mini-Cog,33–34, 162
MoCA (Montreal Cognitive Assessment),57
Modelscategorical model,6–7, 50
cluster model of personality disorders,62
dimensional,43
Five-Factor Model,62
Mood,30.
See also Dysphoric mood; Emotions
Mood disorder,90
Mood disturbances,82
Narcissistic personality disorder dimensional diagnosis of,254–256
in DSM-5-TR,175–176
Narcolepsy, in DSM-5-TR,118–119
National Institute of Mental Health (NIMH),261.
See also Research Domain Criteria (RDoC)
Nervios,46
Neurocognitive disorders.
See also Delirium
case example of,56–59
causes of,59
development of,57
in DSM-5-TR,162–168,
201DSM-5-TR criteria for,57–58
Neurodevelopmental disorders, in DSM-5-TR,71–79,
196Nocturnal sleep polysomnography,118
Nonsuicidal self-injury disorder,49
“Normality,” questions about,207
Nutritional deficiency,112.
See also Feeding and eating disorders
Obsessions,31.
See also Compulsions
Obsessive-compulsive and related disordersdimensional diagnosis of,245–247
in DSM-5-TR,96–99,
200Obsessive-compulsive personality disorder, in DSM-5-TR,177–178
Obstructive sleep apnea hypopnea, in DSM-5-TR,119–120
Occupational problems,189Open City,37
Opioid intoxication, in DSM-5-TR,149
Opioid use disorder, in DSM-5-TR,147–148
Opioid withdrawal, in DSM-5-TR,149–150
Other conditions that may be a focus of clinical attention, in DSM-5-TR,182–183,
183–
192Other (or unknown) substance intoxication, in DSM-5-TR,161
Other (or unknown) substance use disorder, in DSM-5-TR,159–161
Other (or unknown) substance withdrawal, in DSM-5-TR,161
Outline for Cultural Formulation (OCF),20
Panic disorder, in DSM-5-TR,93–95,
199Paranoid personality disorder, in DSM-5-TR,170–171
Paraphilia,179–180
Paraphilic disorders, in DSM-5-TR,179–181
Parkinson’s disease,167
Parsons, Talcott,8
Patientcommunication with,22
confidentiality,22
developmental history,32
history of present illness,29
ideal,23
outline of 15-minute diagnostic interview,38–40
panic-ridden,42
past medical history,32
past psychiatric history,29
physical health of,36
prognosis of,36–37
psychiatric history of,39–40
question outline of 30-minute diagnostic interview,28–34
safety of,29–30
social and cultural needs,36
social history,32–33
violence on first encounter with,21–22
Pattern recognition,35
Pedophilic disorder,180
Personality,32
Personality disorders.
See also Attention-seeking; Dimensional diagnosis of personality disorders; Grandiosity; Level of Personality Functioning Scale; Paranoid personality disorder, in DSM-5-TR; Personality trait rating form; Schizoid personality disorder, in DSM-5-TR
alternative in DSM-5-TR,178–179
case example of,59–60
categorical cluster model of,62
dimensions and,60–61
in DSM-5-TR,169–179
DSM-5-TR criteria for,60–64
Personality trait rating form,238,
239–
242Personality traitsmaladaptive,62
strength-based, 2Persuasion and Healing: A Comparative Study of Psychotherapy (Frank and Frank 1991),16–17
Phencyclidine or other hallucinogen intoxication, in DSM-5-TR,144
Phencyclidine or other hallucinogen use disorder, in DSM-5-TR,142–144
Phobias.
See Specific phobias
Pica,45, 112
Posttraumatic stress disorder (PTSD)in DSM-5-TR,99–103
gender and,48
Power Threat Meaning Framework (PTM),259–260
Prion disease,166
PROMIS Emotional Distress—Anxiety assessment,42
The Psychiatric Interview in Clinical Practice,14
Psychiatry, recommendation for treatment,36
Psychoanalysis,16
Psychodynamic Diagnostic Manual (PDM-2),258
Psychosis,30.
See also Clinical-Rated Dimensions of Psychosis Symptom Severity; Psychotic disorder
Psychosocial functioning,112.
See also Feeding and eating disorders
Psychotic disorder,53.
See also Clinician-Rated Dimensions of Psychosis Symptom Severity; Psychosis; Schizophrenia; Schizotypal personality disorder
substance/medication-induced,54
Psychotic symptoms,82
Pyromania,133
Questions.
See Diagnostic interview; 15-minute diagnostic interview; 30-minute diagnostic interview
to a differential diagnosis,203–207
Rapid eye movement (REM) sleep,118
Rating scales,262.
See also Diagnostic systems and rating scales; Personality trait rating form
Reactive attachment disorder, in DSM-5-TR,103–104
Reality testing,53
Relationships,74.
See also Therapeutic alliance
problems with,189Religion,52.
See also Culture Reordered disorders, DSM-5-TR criteria for, 64–65
Research Domain Criteria (RDoC),261
Restless legs syndrome, in DSM-5-TR,120–121
Risk taking.
See Safety
Roberts, Laura,4
Routines,75
Rumination disorder,112.
See also Feeding and eating disorders
Safety.
See also Violence
of patient,29–30, 38
steps necessary to obtain,36
Schizoaffective disorder, in DSM-5-TR,197Schizoid personality disorder, in DSM-5-TR,171–172
Schizophrenia.
See also Delusions; Disorganized speech; Hallucinations; Psychotic disorder
case example of,51–53
dimensions and,42
in DSM-5-TR,197DSM-5-TR criteria for,51–53
treatment,53
Schizophrenia spectrum and other psychotic disorders, in DSM-5-TR,79–82,
197Schizotypal personality disorderdimensional diagnosis of,249–251
in DSM-5-TR,172–173
Sedative, hypnotic, or anxiolytic intoxication, in DSM-5-TR,152
Sedative, hypnotic, or anxiolytic use disorder, in DSM-5-TR,150–152
Sedative, hypnotic, or anxiolytic withdrawal, in DSM-5-TR,152–153
Self-esteem,85
Self-image,100
Self-Rated Level 1 Cross-Cutting Symptom Measure,41–42
Sensory input,75
Severe Personality Disorders (Kernberg 1984),23–24
Sex.
See also Gender; Gender dysphoria, in DSM-5-TR; Men; Women
diagnostic issues and,48–49
Sexual dysfunctions, in DSM-5-TR,121–127
Sexual masochism disorder,179
Sexual sadism disorder,180
Shenjing shuairo,46
Shweder, Richard,10–11
“Sick role,”8–9
Sleeping,31
decreased need for,85
disturbances in,101
Sleep-wake disorders, in DSM-5-TR,114–121
Social-emotional reciprocity,74
Social environment problems,190–
191Somatic concerns,31
Somatic symptom and related disorders, in DSM-5-TR,106–109
Somatic symptom disorder, in DSM-5-TR,107–108
Specific phobias, in DSM-5-TR,92–93
Specifiers.
See specific disordersSpeech,72–73
disorganized,80
mental status examination during,210
repetitive,75
stereotyped,75
Stimulant intoxication, in DSM-5-TR,155–156
Stimulant use disorder, in DSM-5-TR,153–155
Stimulant withdrawal, in DSM-5-TR,156–157
Stressors.
See Trauma- and stressor-related disorders Substance addictions,31–32
questions related to,204
Substance intoxication,90
Substance-related and addictive disorders, in DSM-5-TR,134–162
Substance withdrawal,90
Subtypes.
See specific disordersSuicidal behavior,183Suicidal thoughts, associations with,49
Suicideas bidirectional,49
conceptualization of,49
Susto,46
Symptoms.
See also specific disordersmeasurement of,41
personalizing diagnoses through dimensions and,41
Systems, review of,30–32, 39
Taijin kyofusho,46
Talkativeness,85
Talking excessively,78
Tasks,77
Telepsychiatry,56–57
Therapeutic alliance.
See also Culture
bonds during,20–25
building,18–25
cognitive-behavioral therapy and,15–16
goals of,18, 217–219,
219–
220tasks for,18–20
30-minute diagnostic interview.
See also Diagnostic interview; 15-minute diagnostic interview
outline of,28–34
pattern recognition during,35
presenting,34–37
Thought content, mental status examination during,212
Thought process, mental status examination during,211–212
Tics,76–77
Tobacco use disorder, in DSM-5-TR,157–158
Tobacco withdrawal, in DSM-5-TR,158–159
Transvestic disorder,180
Trauma,31.
See also Trauma- and stressor-related disorders
Trauma- and stressor-related disorders, in DSM-5-TR,99–104,
200Traumatic brain injury,166
Trichotillomania,99
Violence.
See also Safety
on first encounter with patient,21–22
Voyeuristic disorder,179
Weil, Simone,23
Well-being,18, 63
Women.
See also Female orgasmic disorder; Female sexual interest/arousal disorder; Gender dysphoria
mood changes in,89–90
PTSD and,48
World Health Organization Disability Assessment Schedule 2.0,11–12, 227
Yager, Joel, questions for patients,19–20
Z codes,57, 63,
182